Multiple gestation pregnancies are increasing in incidence due to assisted reproductive technologies and delayed childbearing. These pregnancies are at higher risk for maternal and fetal complications including hypertension, preterm birth, and growth discordance between twins. Prenatal surveillance includes regular ultrasounds to monitor fetal growth, well-being, chorionicity, and complications like twin-twin transfusion syndrome. Mode of delivery depends on fetal presentation, with vertex-vertex twins usually aiming for vaginal delivery while other presentations may require cesarean. Higher-order multiples generally require cesarean delivery for safety.
Presentation at Chittaranjan Seva Sadan, Kolkata where Dr Dasgupta was invited as faculty in the CME organized by Medical Education and research Committee, Bengal Obstetrics and Gynaecological Society
Presentation at Chittaranjan Seva Sadan, Kolkata where Dr Dasgupta was invited as faculty in the CME organized by Medical Education and research Committee, Bengal Obstetrics and Gynaecological Society
Manegement of adenexal masses in pregnancyWafaa Benjamin
Over the last 20 years, the use of ultrasound in pregnancy has dramatically increased the numbers of ovarian cysts diagnosed.
The majority of these ovarian cysts in pregnancy either resolve spontaneously or are due to benign conditions.
Ovarian cancer is extremely rare in women of childbearing age and thus most of these cysts can be managed conservatively.
In terms of malignancy potential, those that are malignant are likely to be borderline.
Unless there is a suspicion of malignancy or there is a significant cyst complication, such as torsion, surgery is not indicated.
MRI is a safe and useful tool to help evaluate cysts in more detail in situations where ultrasound provides an inconclusive answer.
If surgery is planned, this should take place during the second trimester to minimise the risk of miscarriage.
Whether surgery is done laparoscopically or using a traditional open approach, it is largely dependent on operator experience and patient preference.
Aspiration of ovarian cysts is only indicated where they appear simple on ultrasound and where they are causing pain or are thought to be obstructing the birth canal.
If surgery does not take place, then ultrasound follow-up during and after pregnancy may be advised accordingly.
Breast cancer is the most common cancer among American women (American Cancer Society), but only 5-10 percent of breast cancer cases are hereditary. Of those cases, roughly 20-25 percent are linked to mutations in the BRCA1 and BRCA2 genes (BRCA stands for BReast CAncer susceptibility). View the infographic above for more on the genetics of breast cancer.
For more information on breast cancer, visit the website for Dana-Farber’s Susan F. Smith Center for Women’s Cancers Breast Oncology Program: http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Breast-Cancer.aspx
The incidence of multiple gestation continues to increase, and now accounting for more than 3% of all live births.
Twin pregnancies and higher-order multiple births comprise an increasing proportion of the total pregnancies in the developed world due to the expanded use of fertility treatments and older maternal age at childbirth.
Multiple gestation is associated with:
Increase in neonatal morbidity and mortality rates.
Increase in maternal complications at least two folds.
The number of triplet, quadruplet, and higher-order multiple births peaked in 1998 and has dropped slightly recently, most likely because of limits in the number of embryos transferred and because of the availability and acceptance of multifetal pregnancy reduction (MFPR) procedures.
Prematurity, monochorionicity, and growth restriction pose the main risks to fetuses and neonates in multiple gestations.
The mean duration of pregnancy is 35.3 weeks for twin gestations, 31.9 weeks for triplets, and 29.5 weeks for quadruplets.
Stillbirth rates increase from 6.8 /1000 for singletons to 16.1 for twins and to 21.5 for triplets, and infant mortality rates increase from 5 to 23.4 and to 51.2 /1000 births, respectively.
Infants of multiple gestations comprise almost one quarter of very-low-birth-weight infants.
The incidence of severe handicap among neonatal survivors of multiple gestation is also increased: 34.0 and 57.5 /1000 twin and triplet survivors, respectively, compared with 19.7 /1000 singleton survivors.
Maternal morbidity is significantly increased in mothers with multiple gestations and is apparently related to the number of fetuses.
Multiple gestations are associated with significantly higher risks for:
Hypertension
Placental abruption
Preterm labor (78%)
Preeclampsia (26%);
HELLP syndrome (9%) (hemolysis, elevated liver enzymes, low platelets)
Anemia (24%)
Preterm premature rupture of membranes (pPROM) (24%)
Gestational diabetes (14%)
Acute fatty liver (4%)
Chorioendometritis (16%)
Postpartum hemorrhage (9%)
Twins can be dizygotic (DZ), resulting from the fertilization of two separate ova during a single ovulatory cycle.
DZ twins have dichorionic-diamniotic (DCDA) placentas, although these may fuse during pregnancy.
Monozygotic (MZ), resulting from a single fertilized ovum that subsequently divides into two separate individuals.
In MZ twins, the timing of egg division determines placentation (تكون المشيمة):
Diamniotic, dichorionic (DCDA) placentation occurs with division prior to the morula stage (within 3 days post fertilization).
Diamniotic, monochorionic (MCDA) placentation occurs with division between 4-8 days postfertilization.
Monoamniotic, monochorionic (MCMA) placentation occurs with division between 8-12 days postfertilization.
Division at or after day 13 results in conjoined twins.
Manegement of adenexal masses in pregnancyWafaa Benjamin
Over the last 20 years, the use of ultrasound in pregnancy has dramatically increased the numbers of ovarian cysts diagnosed.
The majority of these ovarian cysts in pregnancy either resolve spontaneously or are due to benign conditions.
Ovarian cancer is extremely rare in women of childbearing age and thus most of these cysts can be managed conservatively.
In terms of malignancy potential, those that are malignant are likely to be borderline.
Unless there is a suspicion of malignancy or there is a significant cyst complication, such as torsion, surgery is not indicated.
MRI is a safe and useful tool to help evaluate cysts in more detail in situations where ultrasound provides an inconclusive answer.
If surgery is planned, this should take place during the second trimester to minimise the risk of miscarriage.
Whether surgery is done laparoscopically or using a traditional open approach, it is largely dependent on operator experience and patient preference.
Aspiration of ovarian cysts is only indicated where they appear simple on ultrasound and where they are causing pain or are thought to be obstructing the birth canal.
If surgery does not take place, then ultrasound follow-up during and after pregnancy may be advised accordingly.
Breast cancer is the most common cancer among American women (American Cancer Society), but only 5-10 percent of breast cancer cases are hereditary. Of those cases, roughly 20-25 percent are linked to mutations in the BRCA1 and BRCA2 genes (BRCA stands for BReast CAncer susceptibility). View the infographic above for more on the genetics of breast cancer.
For more information on breast cancer, visit the website for Dana-Farber’s Susan F. Smith Center for Women’s Cancers Breast Oncology Program: http://www.dana-farber.org/Adult-Care/Treatment-and-Support/Breast-Cancer.aspx
The incidence of multiple gestation continues to increase, and now accounting for more than 3% of all live births.
Twin pregnancies and higher-order multiple births comprise an increasing proportion of the total pregnancies in the developed world due to the expanded use of fertility treatments and older maternal age at childbirth.
Multiple gestation is associated with:
Increase in neonatal morbidity and mortality rates.
Increase in maternal complications at least two folds.
The number of triplet, quadruplet, and higher-order multiple births peaked in 1998 and has dropped slightly recently, most likely because of limits in the number of embryos transferred and because of the availability and acceptance of multifetal pregnancy reduction (MFPR) procedures.
Prematurity, monochorionicity, and growth restriction pose the main risks to fetuses and neonates in multiple gestations.
The mean duration of pregnancy is 35.3 weeks for twin gestations, 31.9 weeks for triplets, and 29.5 weeks for quadruplets.
Stillbirth rates increase from 6.8 /1000 for singletons to 16.1 for twins and to 21.5 for triplets, and infant mortality rates increase from 5 to 23.4 and to 51.2 /1000 births, respectively.
Infants of multiple gestations comprise almost one quarter of very-low-birth-weight infants.
The incidence of severe handicap among neonatal survivors of multiple gestation is also increased: 34.0 and 57.5 /1000 twin and triplet survivors, respectively, compared with 19.7 /1000 singleton survivors.
Maternal morbidity is significantly increased in mothers with multiple gestations and is apparently related to the number of fetuses.
Multiple gestations are associated with significantly higher risks for:
Hypertension
Placental abruption
Preterm labor (78%)
Preeclampsia (26%);
HELLP syndrome (9%) (hemolysis, elevated liver enzymes, low platelets)
Anemia (24%)
Preterm premature rupture of membranes (pPROM) (24%)
Gestational diabetes (14%)
Acute fatty liver (4%)
Chorioendometritis (16%)
Postpartum hemorrhage (9%)
Twins can be dizygotic (DZ), resulting from the fertilization of two separate ova during a single ovulatory cycle.
DZ twins have dichorionic-diamniotic (DCDA) placentas, although these may fuse during pregnancy.
Monozygotic (MZ), resulting from a single fertilized ovum that subsequently divides into two separate individuals.
In MZ twins, the timing of egg division determines placentation (تكون المشيمة):
Diamniotic, dichorionic (DCDA) placentation occurs with division prior to the morula stage (within 3 days post fertilization).
Diamniotic, monochorionic (MCDA) placentation occurs with division between 4-8 days postfertilization.
Monoamniotic, monochorionic (MCMA) placentation occurs with division between 8-12 days postfertilization.
Division at or after day 13 results in conjoined twins.
A multifetal pregnancy is a pregnancy in which there are two or more fetuses in the uterus at the same time. This can include twin pregnancies, triplet pregnancies, and higher-order multiple pregnancies.
The most common type of multifetal pregnancy is twin pregnancy, which can be either fraternal (dizygotic) twins, which are formed from two separate eggs fertilized by two separate sperm, or identical (monozygotic) twins, which are formed when a single fertilized egg splits and develops into two separate embryos.
Risk factors for multifetal pregnancy include:
Advanced maternal age
Assisted reproductive technologies (ART) such as in vitro fertilization (IVF)
A family history of twin pregnancies
Use of ovulation-inducing drugs
The management of multifetal pregnancies can be challenging and requires close monitoring and specialized care. It can include ultrasound monitoring to assess the growth and well-being of each fetus, and to detect any potential complications such as twin-to-twin transfusion syndrome (TTTS) or selective intrauterine growth restriction (sIUGR).
Due to the increased risk of complications, multifetal pregnancies are at a higher risk of preterm labor, cesarean delivery, and perinatal morbidity and mortality.
It's important to note that multifetal pregnancies should be managed by a team of specialists such as obstetricians, perinatologists, and pediatricians with experience in the care of multifetal pregnancies.
Women carrying multiple gestations may be initially asymptomatic or may have normal signs and symptoms of pregnancy (eg, breast tenderness, fatigue, nausea, vomiting). Multiple gestations may be suspected in the setting of hyperemesis gravidarum or in a patient who has undergone assisted reproductive technology.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
4. MATERNAL ADAPTATIONS
1. Serum progesterone
2. Estradiol, estriol
3. hPL
4. hCG
5. AFP
Higher than in singleton gestations
5. MATERNAL ADAPTATIONS
↑ Heart rate and stroke volume
↑ Cardiac output and cardiac index
Mean maternal blood pressures at term are significantly higher
Plasma volume increases by 50%-100%→ 𝑫𝑰𝑳𝑼𝑻𝑰𝑶𝑵𝑨𝑳 𝑨𝑵𝑬𝑴𝑰𝑨
Further increase in tidal volume and oxygen consumption ---
more alkalotic arterial pH
6. • Recommendations for maternal weight gain
• Normal weight 37 – 54 lb
• Overweight 31 - 50 lb
• Obese 25 - 42 lb
7. ULTRASONOGRAPHY IN MULTIPLE GESTATION
1. Confirming a diagnosis of multiple gestation
2. Chorionicity
3. Fetal anomalies
4. Guiding invasive procedures
5. Fetal growth
6. Measuring cervical length
7. Fetal well being
8. Preparing for delivery
8. DIAGNOSIS OF MULTIPLE GESTATION
• 5 weeks - Multiple gestational sacs with yolk sacs
• 6 weeks- with cardiac activity
9. CHORIONICITY
• Best performed in the 1st trimester
• DICHORIONIC
- clearly separate gestational sacs, each surrounded by a thick
echogenic ring before 8 weeks gestation
MONOCHORIONIC
- separate echogenic rings are not visible
10. • DIAMNIONIC
2 fetal poles with 2 yolk sacs in a monochorionic gestation
• MONOAMNIONIC
2 fetal poles and 1 yolk sac
11. Detection of fetal anomalies
• 83% rate of detecting fetuses with Down syndrome in twin
pregnancies achieved by combining risks derived from maternal age
and nuchal translucency thickness measurement at 10-14 weeks
• Finding of increased nuchal translucency in one fetus of a
monochorionic pair may predict the development of TTTS
12. Evaluation of fetal growth
• Serial ultrasonography
-most accurate method to assess fetal growth in cases of
multiple gestation
Weight discordance
-indication for close fetal surveillance rather than indication for
immediate delivery
> 20 % important predictor for adverse perinatal outcomes
13. Measurement of cervical length
• Can identify those at increased risk for preterm delivery
• Done every 2 weeks from 16- 24 weeks gestation
• Major limitation:
• Lack of proven effective intervention when a short cervix is noted
14. Confirmation of fetal well being
1. Biophysical profile
2. Doppler velocimetry
3. Amniotic fluid volume
a. a single overall AFI without reference to the dividing membrane
b. Individual AFI for each sac
c. largest two-diameter pocket in each sac
d. subjective assessment of the relative distribution of fluid between sacs
15. ANTEPARTUM MANAGEMENT
Fetal surveillance
-serial ultrasound every 3-4 weeks from 18 weeks gestation in
dichorionic twins or every 2 weeks if growth restriction or
growth discordance is discovered.
-for monochorionic twins, serial growth scans are performed
every 2 weeks from 16 weeks gestation
16. Indications for NST with BPP
1. Significant growth restriction in either fetus
2. Growth discordance (>18%)
3. Oligohydramnios
4. Decreased fetal movement
5. Maternal medical complications
17. FETAL SURVEILLANCE
Growth discordance
• Twice-weekly NST
• BPP
• Umbilical artery Doppler velocimetry
If absent or reversed end-diastolic flow is discovered, delivery should be
considered if gestational age is sufficiently advanced
18. INTRAPARUM MANAGEMENT
• TIMING OF DELIVERY
38 weeks- nadir of perinatal mortality for dichorionic twins
All twin fetuses should be delivered by 39 weeks of gestation because
of the rising morbidity and mortality beyond that date
19. Intrapartum management
PREPARATIONS
Prostaglandins- for induction of labor
Oxytocin- for induction or augmentation
VBAC
- No randomized studies that confirm the safety of VBAC in multiple
gestation
- Requires multidiscpilinary cooperation:
- OB and nursing staff
- Anesthesiologist
- At least one neonatologist or pediatrician
Intravenous access and prompt availability of blood products
20. INTRAPARTUM MANAGEMENT
• Ultrasound should be performed as soon as possible after admission
to determine fetal presentation
• Electronic fetal monitor should be available
• Continous Lumbar Epidural anesthesia is strongly recommended if
trail of labor is chosen
• Vaginal delivery should be performed in an operating room because
CS may be required for the second twin in a small number of cases
21. VERTEX-VERTEX TWINS
• Occurs in 40-45% of all twin pregnancies
• In the absence of obstetric indications, vaginal birth should be
planned regardless of gestational age
• No absolute indication to deliver the second twin within a specified
time limit
• Active intervention to complete the delivery is encouraged by studies
that link length of interval to fetal acid-base status
22. VERTEX-NONVERTEX TWINS
• Occurs in 35-40% of all twin pregnancies
• Mode of delivery depends on:
1. Size of the second twin
2. Presence of growth discordance
3. Availability of obstetric staff skilled in breech delivery, internal podalic
version and total breech extraction
-the adverse perinatal outcome associated with breech second twin is more
often related to prematurity or growth restriction rather than the mode of
delviery
23. Vertex- nonvertex twins
• Vaginal delivery can be offered for the nonvertex second twin if the
estimated fetal weight is 1500-3500 grams provided it is not
significantly larger than the 1st twin and the head is not
hyperextended
24. NONVERTEX FIRST TWIN
• Occurs in 15-20% of all twin pregnancies
• Almost always managed by Cesarean delivery because of concerns
about interlocking fetal heads
25. HIGHER-ORDER MULTIPLE
GESTATIONS
• Cesarean delivery under regional anesthesia is recommended
because of the difficulties in adequately monitoring three or more live
fetuses that are of a viable gestational age in labor and through
delivery
26. ASYNCHRONOUS DELIVERY
• Delivery of one fetus in a multiple gestation that is not followed
promptly by birth of the remaining fetus
• Acceptable only in the management of extreme prematurity
• CONTRAINDICATIONS
• Monochorionicity
• Intramnionic infection
• Placental abruption
• Co-existence of preeclampsia
27. TWIN-TWIN TRANSFUSION SYNDROME
• Occurs exclusively in monochorionic twin pregnancies
• imbalance in blood flow through the vascular communications in the
placenta, which leads to overperfusion of one twin and
underperfusion of its co-twin
28. TTTS: Clinical and Sonographic Features
DONOR
• Hypoperfused
• IUGR
• Oligohydramnios/anhydramnios
• Stuck twin appearance
• Lower hematocrit
• EKG: no specific finding
RECIPIENT
• Hyperperfused
• Hypertensive
• Biventricular hypertrophy
• Diastolic dysfunction
• Polyhydramnios
• EKG: ventricular hypertrophy
and dilation, TR and cardiac
failure
29. TWIN-TWIN TRANSFUSION SYNDROME:
ULTRASONOGRAPHIC CRITERIA
1. Single placenta
2. Sex concordance
3. 20% growth discordance
4. Oligohydramnios and polyhydramnios
5. Umbilical cord size discrepancy
6. Presence of fetal hydrops or cardiac dysfunction
7. Abnormal umbilical artery Doppler findings
30. QUINTERO STAGING
Stage I: Donor twin bladder visible, fetal Doppler values normal
Stage II: Donor twin bladder not visible, fetal Doppler values normal
Stage III: Donor twin bladder not visible, fetal Doppler values critically
abnormal
Stage IV: Hydrops
Stage V: Intrauterine death of one or both fetuses
33. TWIN ANEMIA POLYCYTHEMIA SEQUENCE
(TAPS)
• Middle cerebral artery peak systolic velocity (PSV) > 1.5 MoM in one
fetus (anemic ex-recipient), and
• PSV < 0.8 MoM in the other fetus (polycythemic ex-donor fetus)
• May occur in 13% of cases of TTTS treated with laser and
spontaneously seen in 5% of monochorionic twins that had never
been diagnosed with TTTS
35. MONOAMNIOTIC TWINS
• Single amniotic sacs containing both twins
• 1% of monozygotic twins
• Increased perinatal risk
• Premature delivery
• Growth restriction
• Congenital anomalies
• Vascular anastomosis between twins
• Umbilical cord entanglement
36. MONOAMNIOTIC TWINS
Management
SULINDAC
-Prostaglandin inhibitor that decrease AFV
→stabilize fetal lie and reduce the risk for cord
entanglement
-only intervention proposed to reduce cord accidents
Daily NST
-beginning at 24-26 weeks to determine the frequency of
variable deceleration
38. TWIN REVERSED ARTERIAL PERFUSION
SEQUENCE (TRAPS)
• Acardiac twinning
• A unique abnormality of monochorionic multiple gestations
• One twin has an absent, rudimentary/non-functioning heart
• 1% of monozygotic twin
• Occurs because of early 1st trimester circulatory failure of one fetus in
a monochorionic twin pregnancy, together with the development of
arterioarterial or venovenous anastomoses between the umbilical
arteries of both fetuses
39. TWIN REVERSED ARTERIAL PERFUSION
SEQUENCE (TRAPS)
Management:
fetoscopic surgery- cord interruption at 16-18 weeks,
before features of cardiac decompensation develop
40. CONJOINED TWINS
• Subset of monozygotic twin gestation which incomplete embryonic division
occurs 13-15 days after conception
• 1.5/100,000 births
• Prenatal diagnosis:
-failure to visualize two fetuses separately in what appears to be a
single amniotic sac
-BIFID APPEARANCE OF THE 1ST TRIMESTER FETAL POLE
-MORE THAN 3 UMBILICAL CORD VESSELS
-HEAD PERSISTENTLY AT THE SAME LEVEL AND BODY PLANE
-FAILURE of the fetuses to change position relative to each other over
time
42. CONJOINED TWINS
• Expectant management
Fetal echocardiography and MRI to delineate exact extent of union and assist in
neonatal surgical planning
Classical Cesarean section – delivery method of choice to minimize maternal
and fetal trauma
43. INTRAUTERINE DEMISE OF ONE FETUS
• Common during the 1st trimester
• At 12 weeks gestation, can result in profound neurologic injury and
increased risk of SGA in the surviving fetus
Neurologic injury occurs because of the significant hypotension at the
time of death of the co-twin
Preeclampsia in higher order MG occurs at an earlier gestational age, more severe and more likely to have an atypical clinical presentation than preeclampsia in singleton gestations.
THE NORMAL MATERNAL PHYSIOLOGIC ADAPTATIONS SEENN IN singleton pregnancy are exaggerated in MG.
Doppler: umbilical artery whenever MG is complicated by significant growth restriction or discordance
There is no agreement on the optimal sonographic method to assess AFV in MG. methods in use include
Amniotomy and oxytocin augmentation
In the absence of skilled OB or if the second twin is significantly larger than the first, caesarean delivery is recommended.
Stuck twin because of its inability to visualize the dividing membrane separate from the fetal body
Absent end diastolic flow in the donor fetus
Not all sonographic criteria need to met to make the dx of TTTS
SONOGRAPHIC SCORING CRITERIA to classify severity of TTTS
First 2 were abandoned because they do nothing to interfere with the underlying placental disease pathology
3rd is the mose effective management --- of the anastomoctic vessels on the surface of the placenta
Only therapy that directly treats the underlying pathophysiology of TTTS
The procedure is performed in an operating room. After the patient’s abdomen has been washed with an antiseptic and covered with sterile paper drapes, an ultrasound is performed to determine the appropriate spot to enter the uterus. The skin is then injected with an anesthetic medication. An anesthesiologist will also administer medications through an intravenous line to produce sedation. A small skin cut is made to allow the introduction of a thin hollow tube and needle. The instruments are inserted under ultrasound guidance into the amniotic sac of the recipient twin. The needle is removed and a telescope (fetoscope) with a thin fiber to carry the laser energy is then inserted through the hollow tube. The fetoscope is used to look directly at the blood vessels on the surface of the placenta. Vessels that are found to communicate between the twins are then closed using laser light energy. At the completion of the surgery, the extra amniotic fluid in the recipient twin’s sac is removed to achieve a normal volume.
Because the fetoscope requires a larger hole to be made into the amniotic cavity than would be the case with an amnioreduction or septostomy procedure, laser ablation is associated with a higher risk of complications such as premature contractions, premature rupture of the membranes (15 - 20% of cases), placental separation (2%), and infection. For this reason, special medications to prevent contractions and antibiotics to prevent infection will be given before and after the procedure. In addition, laser therapy may be associated with unique risks since the laser energy may cause certain areas of the placenta or blood vessels on the surface of the placenta to bleed.
Laser ablation has been shown to result in the survival of at least one twin in 70 - 80% cases and both twins in 1/3 of cases.5, 7, 8 Should one fetus die after the procedure, the likelihood that the surviving fetus will develop complications is reduced from the 35% to approximately 7%. This is because the babies are no longer sharing blood vessels between them. In 1/3 of cases, neither twin will survive. Studies to date have indicated that approximately 8% of survivors following laser ablation will have a long-term mental handicap. This is approximately half of the rate of problems seen in survivors treated with amnioreduction.5